APA (7th ed.) Citation

Matur, R. V., Thuluva, S., Gunneri, S., Yerroju, V., reddy Mogulla, R., Thammireddy, K., . . . Narayan, J. P. (2024). Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study. Vaccine, 42(13), 3157-3165. https://doi.org/10.1016/j.vaccine.2024.03.056

Chicago Style (17th ed.) Citation

Matur, Ramesh V., et al. "Immunogenicity and Safety of a 14-valent Pneumococcal Polysaccharide Conjugate Vaccine (PNEUBEVAX 14™) Administered to 6–8 weeks Old Healthy Indian Infants: A Single Blind, Randomized, Active-controlled, Phase-III Study." Vaccine 42, no. 13 (2024): 3157-3165. https://doi.org/10.1016/j.vaccine.2024.03.056.

MLA (9th ed.) Citation

Matur, Ramesh V., et al. "Immunogenicity and Safety of a 14-valent Pneumococcal Polysaccharide Conjugate Vaccine (PNEUBEVAX 14™) Administered to 6–8 weeks Old Healthy Indian Infants: A Single Blind, Randomized, Active-controlled, Phase-III Study." Vaccine, vol. 42, no. 13, 2024, pp. 3157-3165, https://doi.org/10.1016/j.vaccine.2024.03.056.